PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

Clinical trials for PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) explained in plain language.

Never miss a new study

Get alerted when new PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) trials appear

Sign up with your email to follow new studies for PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Finding the right dose: study tests treatment for rare childhood nerve disease

Disease control Recruiting now

This study aims to find the best dose of a medicine called Privigen (IVIG) to control symptoms and prevent relapse in children aged 2-17 with chronic inflammatory demyelinating polyneuropathy (CIDP), a rare nerve disorder. Researchers will compare two different dose levels to see…

Matched conditions: PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

Get alerted when new PEDIATRIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) trials appear

Finding the right dose: study tests treatment for rare childhood nerve disease